|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 235/22 | (2006.01) |
| (11) | Number of the document | 3572405 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19185319.1 |
| Date of filing the European patent application | 2015-09-14 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation | 2023-10-25 |
| (30) | Number | Date | Country code |
| 201462050023 P | 2014-09-12 | US |
| (72) |
RESNICK, Lynn , US
TOPALOV, George T , US
BOYD, Steven A. , US
BELARDI, Justin K. , US
FLENTGE, Charles A. , US
HALE, James S. , US
HARRIED, Scott S. , US
MARESKA, David A. , US
ZHANG, Kai , US
|
| (73) |
Biohaven Therapeutics Ltd. ,
215 Church Street, New Haven, CT 06510,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Benzoimidazol-1,2-ilo amidai, kaip Kv7 kanalų aktyvatoriai |
| BENZOIMIDAZOL-1,2-YL AMIDES AS KV7 CHANNEL ACTIVATORS |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 11 | 289.00 EUR |
| 2026-09-14 |